MEL 90 Excimer Laser
Carl Zeiss Meditec, Inc. · Decision date Apr 30, 2026
What did the FDA decide?
FDA records P060004/S011 as a supplement to PMA P060004, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Apr 30, 2026.
FDA approval order statement
updates to the quality inspection process for the Fluence Test Cards
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Ophthalmic
- Decision date
- Apr 30, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P060004/S011
- Regulatory pathway
- PMA supplement
- Applicant
- Carl Zeiss Meditec, Inc.
- Product code
- LZS
- Decision code
- OK30
- Decision date
- Apr 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Excimer laser system.
- Applicant
- Carl Zeiss Meditec, Inc.
- Product code
- LZS
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P060004/S011 received
Application receipt date recorded by FDA.
P060004/S011 · FDA decision
30-Day Notice
P060004/S010 · Related supplement
MEL 90 Excimer Laser
Timeline entries are records held by MedtechLedger for P060004. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P060004
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MEL 90 Excimer LaserP060004/S010 | Carl Zeiss Meditec, Inc. | PMA supplement | Jul 1, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Carl Zeiss Meditec, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 5160 Hacienda Dr., Dublin, CA, 94568
Sources and methodology
- Original FDA record: P060004/S011
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records